Related Experiment Video
Updated: Jun 6, 2026
06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
Primary aldosteronism: what consensus for the diagnosis
Maria-Verena Cicala1, Franco Mantero
1Division of Endocrinology, Department of Medical and Surgical Sciences, University of Padua, Via Ospedale 105, 35128 Padova, Italy. mariaverena.cicala@unipd.it
Best Practice & Research. Clinical Endocrinology & Metabolism
|December 1, 2010
Summary
Primary Aldosteronism (PA), a common cause of hypertension, is increasingly recognized due to the ARR ratio. Current guidelines address diagnosis and treatment, but some issues require further clarification.
Area of Science:
- Endocrinology
- Hypertension Management
- Clinical Practice Guidelines
Background:
- Primary Aldosteronism (PA) involves autonomous aldosterone production, partially independent of the renin-angiotensin system.
- The introduction of the Aldosterone-Renin Ratio (ARR) has significantly increased the recognized prevalence of PA.
- PA is a highly prevalent, identifiable, treatable, and potentially curable form of hypertension, necessitating clinical guidelines.
Purpose of the Study:
- To review and synthesize current clinical practice guidelines for the diagnosis and treatment of Primary Aldosteronism.
- To highlight the significance of the Endocrine Society's consensus guidelines in managing hyperaldosteronism.
- To identify and discuss unresolved issues in PA management that extend beyond current guideline recommendations.
Main Methods:
- Systematic reviews of available evidence were conducted.
- Key treatment and prevention recommendations were formulated based on the evidence.
- Analysis of existing Endocrine Society guidelines for diagnosis and treatment of hyperaldosteronism.
Main Results:
- The Endocrine Society USA has published clinical practice guidelines for PA diagnosis and treatment.
- These guidelines are widely adopted for managing hyperaldosteronism.
- Certain aspects of PA management remain complex and are not fully addressed by current guidelines.
Conclusions:
- Primary Aldosteronism is a critical area in hypertension management due to its prevalence and curability.
- Existing guidelines provide a strong foundation but do not encompass all clinical challenges.
- Further guidance is needed to address the remaining unresolved issues in the diagnosis and treatment of PA.
Related Concept Videos
01:27Adrenal Gland Disorders
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
01:26Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
01:33Hormonal Regulation
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...